Prediction of Nuclear Envelope-related diseases
Agonistic compounds for frizzled-1 and/or frizzled-2 receptors
Antagonistic compounds for frizzled-1 and/or frizzled-2 receptors
ACS Biomarker B.V. closes financing round and appoints new C.E.O. (May 2011)
BioMedbooster's spin-off GlycoCheck interviewed for sprout (Dutch; May 2011)
BioMedbooster interviewed for sprout (Dutch; May 2011)
Established GlycoCheck BV (established 2010: cardiovasculair diagnotic)
Established Psymate BV (established 2010: behaviour changes)
Established X-air BV (established 2010: pulmonary diagnostic)
Henri Theunissen, PhD joined BioMedbooster as Managing Director (November 2009)
